Gilead Extends Push Into Oncology With Agenus R&D Pact

 
• By Sten Stovall
  
SyringeClinic
R&D Pact Provides Gilead Options To 3 Agenus immuno-oncology Assets • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business